LEVOSEMOTIADIL FUMARATE
UNII 1GVF558KQJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Levosemotiadil Fumarate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1GVF558KQJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 116476-17-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1GVF558KQJ

CAS Registry Number

116476-17-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEVOSEMOTIADIL FUMARATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C29H32N2O6S.C4H4O4

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DIEJEELGDWGUCV-NQTKYQIASA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224338

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9939466

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c(ccc2c1OCO2)OCCN(CCCOc3c(cc(cc3)OC)[C@@H]4Sc5c(N(C4=O)C)cccc5)C.C(/C=C/C(=O)O)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Levosemotiadil Fumarate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

LEVOSEMOTIADIL FUMARATE

LEVOSEMOTIADIL FUMARATE [JAN]

Systematic Nomenclature

2H-1,4-BENZOTHIAZIN-3(4H)-ONE, 2-(2-(3-((2-(1,3-BENZODIOXOL-5-YLOXY)ETHYL)METHYLAMINO)PROPOXY)-5-METHOXYPHENYL)-4-METHYL-, (2S)-, (2E)-2-BUTENEDIOATE (1:1)

SYS

2H-1,4-BENZOTHIAZIN-3(4H)-ONE, 2-(2-(3-((2-(1,3-BENZODIOXOL-5-YLOXY)ETHYL)METHYLAMINO)PROPOXY)-5-METHOXYPHENYL)-4-METHYL-, (S)-, (E)-2-BUTENEDIOATE (1:1)

SYS